Hu. Schulz et al., Randomized, placebo-controlled trial of lazaroid effects on severe acute pancreatitis in rats, CRIT CARE M, 29(4), 2001, pp. 861-869
Objectives: To evaluate the therapeutic potential of lazaroids in severe ne
crotizing acute pancreatitis and to investigate the association between oxi
dative stress, protease activation, and local production of proinflammatory
cytokines and the severity and lethality of the disease,
Background: Oxidative stress is a crucial factor in the pathophysiology of
acute pancreatitis and its systemic complications, Treatment with antioxida
nts, however, failed to improve survival in most studies performed so far,
Lazaroids are a novel class of antioxidants that potently protect pancreati
c acinar cells against oxidant attack in vitro,
Design: Prospective, randomized, controlled experimental study.
Setting: University research laboratory.
Subjects: Seventy-five anesthetized male Wistar rats (300-350 g).
Interventions: Severe acute pancreatitis was induced by retrograde injectio
n of 3.5% taurocholate-sodium into the common bile-pancreatic duct. interve
ntions were performed to mimic the clinical situation, including continuous
intravenous fluid substitution and administration of lazaroids in a therap
eutic protocol. Therapy was started 1 hr after injection of the bile salt b
y using three different lazaroids, lactated Ringer's solution (placebo), an
d methylprednisolone as a corticosteroid control (n = 15 in each group). Al
l the substances were given by continuous intravenous infusion throughout t
he 20-hr trial period.
Measurements and Main Results:Pancreatic homogenates and ascites were analy
zed for indicators of oxidative stress, antioxidants, proteases, and proinf
lammatory cytokines, Pancreatic edema, morphologic pancreatitis severity, a
nd pancreatic histopathology also were assessed. All three lazaroids and me
thylprednisolone diminished pancreatic tumor necrosis factor-or concentrati
ons, Lethality was 33% in the placebo group, Neither the lazaroids nor meth
ylprednisolone influenced survival. The local pancreatic and peritoneal con
centrations of lipid peroxidation products, antioxidants, and proteases did
not differ among the five groups. Nonsurviving rats, however, had a higher
total protease activity in the pancreas and higher concentrations of tryps
inogen activation peptide in ascites, as compared with surviving animals. T
here were no differences between survivors and nonsurvivors with regard to
variables of oxidative stress and cytokines,
Conclusions: Lazaroid application under clinically relevant conditions (i.e
,, after induction of fulminant acute pancreatitis) does not influence leth
ality or biochemical variables relevant to this disease, Protease activatio
n rather than oxidative stress or local pancreatic cytokine production is a
n important determinant of disease severity and survival in acute pancreati
tis, In experimental studies evaluating novel therapeutics, the same strict
criteria should be applied as in the human setting.